0001628280-20-011806 Sample Contracts

OPEN MARKET SALE AGREEMENT1
Open Market Sale • August 5th, 2020 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • New York
AutoNDA by SimpleDocs
EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • August 5th, 2020 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • California

Employment Agreement (“Agreement”) made as of the 13th day of April, 2020 by and between Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and Mark McClung (“Executive”) (collectively, the “Parties”).

EIGHTH AMENDMENT TO LEASE
Lease • August 5th, 2020 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)

THIS EIGHTH AMENDMENT TO LEASE (this “Eighth Amendment”) is entered into as of May 29, 2020 (the “Effective Date”), by and between POINT RICHMOND R&D ASSOCIATES II, LLC, a California limited liability company (“Landlord”), and SANGAMO THERAPEUTICS, INC., a Delaware corporation (formerly known as Sangamo Biosciences, Inc., a Delaware corporation) (“Tenant”), with reference to the following facts:

SEVENTH AMENDMENT TO LEASE
Lease • August 5th, 2020 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)

THIS SEVENTH AMENDMENT TO LEASE (this “Seventh Amendment”) is entered into as of May 20, 2020 (the “Effective Date”), by and between POINT RICHMOND R&D ASSOCIATES II, LLC, a California limited liability company (“Landlord”), and SANGAMO THERAPEUTICS, INC., a Delaware corporation (formerly known as Sangamo Biosciences, Inc., a Delaware corporation) (“Tenant”), with reference to the following facts:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!